RE: New partner8 May 2021 18:54
‘partners and potential licensees who have requested this information‘
It’s more than one current partner and more than one potential licensee. Sounds like (not in the least surprised) a lot of interest.
Malvern Panalytical and Pion must surely be included here. The bigger question is, which was raised, are Glaxo, Astra Zeneca, Fuji etc considered partners as these were the companies we were working with on the small sized box prior to the Covid pandemic. I’m not saying they would want the test to produce and sell, (maybe Fuji?) but they do have the ears of Governments and Government’s need to find a way to monitor and identify ALL infected people which currently is rather costly, slow, double testing and piece meal and even unproven to work, it’s only managing to find the infectious. They must also have the ears of the newly formed UKHSA, it may have actually been formed due to the above advice from GSK and Astra, local and national forward planning. The UKHSA is tasked to create a long term bio defence system at scale for the future as well as now. Our device slots right in and may also explain the more thorough pace seeking the absolute highest quality and highest spec for a long lasting system worthy of Governments investing in for this purpose.
We know Paraytec are transferring the lab findings to a commercial product. We know Carl is tweaking and I believe his aim is to match or better the Gold standard PCR and therefore be in a position to offer the world a global defence system it desperately needs in this modern interconnected world.
We then of course have so many additional areas to target with a multitude of Aptamers which currently take approximately 4 weeks to create which future proofs our tech.